This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: CareRx Corporation
Today reported its financial results for the fourth quarter ended December 31, 2024. Revenue for the quarter was $92.2 million as compared to $92.8 million for the third quarter of 2024 and $91.1 million for the fourth quarter of 2023. Adjusted EBITDA for the quarter was $7.6 million as compared to $7.8 million for the third quarter of 2024 and $7.5 million for the fourth quarter of 2023: CareRx Corporation shares T.CRRX are trading down $0.16 at $2.50.
